NewsDialy

Arcadia Biosciences shareholders clear the way for a potential share consolidation and install a new equity program

9/15/2026

A reverse stock split is when a company reduces the number of shares in circulation by merging them, so multiple existing shares become a single share at a proportionally higher price.

Shareholders of Arcadia Biosciences, Inc. (Nasdaq: RKDA) voted on September 10, 2026 to give the board the authority to do exactly that, if it chooses to act before June 30, 2027.

Seven proposals were on the ballot at the Dallas company's annual meeting; all seven passed.

The reverse split: authorized, not decided Holders representing roughly 52.3% of the company's outstanding common stock, or 1,259,315 shares, were present in person or by proxy.